Adendra Therapeutics

Adendra Therapeutics was spun out from the Francis Crick Institute by ATP in 2021. It aims to create a new type of immunotherapy. With new insights into dendritic cell biology, Adendra is committed to discovering and developing novel small molecules and biologics for cancer and other diseases.